CN107362311B - Medicine 'Baicheqingjin' for treating cough - Google Patents
Medicine 'Baicheqingjin' for treating cough Download PDFInfo
- Publication number
- CN107362311B CN107362311B CN201710739223.3A CN201710739223A CN107362311B CN 107362311 B CN107362311 B CN 107362311B CN 201710739223 A CN201710739223 A CN 201710739223A CN 107362311 B CN107362311 B CN 107362311B
- Authority
- CN
- China
- Prior art keywords
- fried
- myrobalan
- qingjin
- bark
- radix stemonae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 92
- 239000003814 drug Substances 0.000 title claims description 46
- 229940079593 drug Drugs 0.000 title claims description 14
- 239000008187 granular material Substances 0.000 claims abstract description 44
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 36
- 235000011517 Terminalia chebula Nutrition 0.000 claims abstract description 36
- 244000277583 Terminalia catappa Species 0.000 claims abstract description 35
- 240000000249 Morus alba Species 0.000 claims abstract description 20
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 20
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 19
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 17
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 17
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 17
- 241000931705 Cicada Species 0.000 claims abstract description 17
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 17
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 17
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 17
- 235000020224 almond Nutrition 0.000 claims abstract description 17
- 240000005790 Oroxylum indicum Species 0.000 claims abstract description 16
- 235000012920 Oroxylum indicum Nutrition 0.000 claims abstract description 16
- 235000016993 Agrimonia Nutrition 0.000 claims abstract description 15
- 240000000774 Cunila origanoides Species 0.000 claims abstract description 14
- 235000018274 Cunila origanoides Nutrition 0.000 claims abstract description 14
- 235000014866 Dictamnus albus Nutrition 0.000 claims abstract description 14
- 235000012054 meals Nutrition 0.000 claims abstract description 10
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000002552 dosage form Substances 0.000 claims abstract description 3
- 241000490229 Eucephalus Species 0.000 claims abstract 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 238000001035 drying Methods 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 239000004375 Dextrin Substances 0.000 claims description 10
- 229920001353 Dextrin Polymers 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 235000019425 dextrin Nutrition 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 239000005720 sucrose Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000008216 herbs Nutrition 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 3
- 239000002674 ointment Substances 0.000 claims 1
- 235000019640 taste Nutrition 0.000 abstract description 8
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 85
- 230000000694 effects Effects 0.000 description 31
- 206010062717 Increased upper airway secretion Diseases 0.000 description 23
- 210000004185 liver Anatomy 0.000 description 23
- 208000026435 phlegm Diseases 0.000 description 23
- 208000006673 asthma Diseases 0.000 description 20
- 238000011160 research Methods 0.000 description 14
- 238000010926 purge Methods 0.000 description 13
- 241001092070 Eriobotrya Species 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 241000132092 Aster Species 0.000 description 8
- 206010042674 Swelling Diseases 0.000 description 8
- 230000002411 adverse Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 201000007100 Pharyngitis Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000003800 pharynx Anatomy 0.000 description 7
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 241000218671 Ephedra Species 0.000 description 6
- 206010068319 Oropharyngeal pain Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 102000004388 Interleukin-4 Human genes 0.000 description 5
- 108090000978 Interleukin-4 Proteins 0.000 description 5
- 206010028748 Nasal obstruction Diseases 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 5
- 235000009330 Terminalia Nutrition 0.000 description 5
- 241001534869 Terminalia Species 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000010085 airway hyperresponsiveness Effects 0.000 description 5
- 208000013116 chronic cough Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 229940028885 interleukin-4 Drugs 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000008070 Interferon-gamma Human genes 0.000 description 4
- 108010074328 Interferon-gamma Proteins 0.000 description 4
- 102000004889 Interleukin-6 Human genes 0.000 description 4
- 108090001005 Interleukin-6 Proteins 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 208000037883 airway inflammation Diseases 0.000 description 4
- 230000001174 ascending effect Effects 0.000 description 4
- 201000004897 cough variant asthma Diseases 0.000 description 4
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 4
- 229960003130 interferon gamma Drugs 0.000 description 4
- 229940100601 interleukin-6 Drugs 0.000 description 4
- 208000010753 nasal discharge Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010062519 Poor quality sleep Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229960002179 ephedrine Drugs 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000002663 nebulization Methods 0.000 description 3
- 210000002741 palatine tonsil Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 231100000611 venom Toxicity 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241001662414 Aster tataricus Species 0.000 description 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241001671204 Stemona Species 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000036428 airway hyperreactivity Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 229960004436 budesonide Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000000125 common agrimony Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- FMCGSUUBYTWNDP-GXSJLCMTSA-N (+)-N-methylpseudoephedrine Chemical compound CN(C)[C@@H](C)[C@@H](O)C1=CC=CC=C1 FMCGSUUBYTWNDP-GXSJLCMTSA-N 0.000 description 1
- OSSRRAHCMATAPN-UHFFFAOYSA-N 2-methyl-5-phenylbenzene-1,3-diol Chemical group C1=C(O)C(C)=C(O)C=C1C1=CC=CC=C1 OSSRRAHCMATAPN-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000007190 Chlamydia Infections Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010052139 Eye oedema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000192656 Nostoc Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000084767 Potentilla indica Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 244000046095 Psophocarpus tetragonolobus Species 0.000 description 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039740 Screaming Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- POQHFALZNYMCBA-UHFFFAOYSA-N Stemonine Natural products CCC1C2C3CCC(C4CC(C)C(=O)O4)N3CCC(=O)C2OC15OC(=O)C(=C5)C POQHFALZNYMCBA-UHFFFAOYSA-N 0.000 description 1
- 241000001522 Terminalia chebula Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- GYOGHROCTSEKDY-UHFFFAOYSA-N Tuberostemonine J Natural products C12N3CCCCC1C(CC)C1OC(=O)C(C)C1C2CC3C1CC(C)C(=O)O1 GYOGHROCTSEKDY-UHFFFAOYSA-N 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000008369 airway response Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229960001985 dextromethorphan Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000000312 effect on influenza Effects 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- UINUUSQOLRQGNF-UHFFFAOYSA-N stemonine Chemical compound O1C2(C=C(C)C(=O)O2)C(CC)C(C2CC3)C1CCCN2C3C1CC(C)C(=O)O1 UINUUSQOLRQGNF-UHFFFAOYSA-N 0.000 description 1
- HTLBMAZNGBFLEY-UHFFFAOYSA-N stemonine-C17 Natural products O1C(=O)C(C)CC1C1N2CCCC3OC(=O)C(C)C3C2CC1 HTLBMAZNGBFLEY-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 229960005105 terbutaline sulfate Drugs 0.000 description 1
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a myrobalan Qingjin granule for treating infantile cough, which comprises the following raw materials in percentage by weight: 4-30g of radix stemonae, 4-30g of myrobalan, 4-30g of fried scutellaria baicalensis, 4-30g of indigo naturalis, 4-30g of sea clam meal, 4-30g of honey-fried edestan, 4-30g of fried white mulberry root-bark, 4-30g of fried aster, 1-30g of oroxylum indicum, 4-30g of hairyvein agrimonia herb and bud, 4-30g of fried loquat leaf, 4-30g of dittany bark, 2-30g of cicada slough, 4-30g of cortex lycii radicis and 4-30g of almond. Starts from the aspects of changing the dosage form, improving the drug effect, enhancing the taste and the like, and is the myrobalan Qingjin granules which are convenient to take, safe and effective.
Description
Technical Field
The invention relates to the field of traditional Chinese medicines, and in particular relates to a myrobalan Qingjin granule for treating infantile cough.
Background
Cough is generally caused by viral infection or mycoplasma, chlamydia infection. Research has shown that about 11% -25% of people suffer from subacute or even chronic cough, and in the epidemic season, the incidence rate of cough after infection can reach 25% -50%, so the disease is very common in pediatric respiratory diseases, and the incidence is in growing trend in recent years. However, the actual pathogenesis of cough after infection is still unclear, and satisfactory treatment is still lacked so far, so that doctors are easy to misdiagnose clinically or other complications are caused; although most children patients can be self-healed, the cough symptoms are stubborn and delayed in the process, and the physical and psychological health of the children patients is also seriously affected, so that unnecessary economic loss and psychological burden are caused, and therefore, the more effective method for treating the cough after the children are infected becomes urgent.
At present, according to the cough diagnosis and treatment guidelines (2009 edition) issued by the respiratory syndrome of the Chinese medical society, asthma group, β 2 receptor agonists (such as tylosin aerosol), glucocorticoid nebulization (such as dexamethasone and budesonide), antitussives (such as dextromethorphan) and the like are mostly selected for symptomatic treatment in western medicine, but the effect is not ideal, side effects such as sleepiness, dry mouth, nausea, constipation and the like may occur, few critically ill children need to inhale or take glucocorticoid to treat symptoms, but the symptoms can be relieved, and the symptoms are often repeated after the medicine is stopped, so that part of doctors unreasonably use antibiotics, which also becomes an important reason for the rise of bacterial drug resistance.
The traditional Chinese medicine has rich experience in treating cough and obvious advantages. Through retrieval, clinical research reports of treating post-infection cough by methods of dispelling wind, dispersing pathogen accumulation, freeing lung, relieving and strengthening body resistance and the like are common at present, but the research of the action mechanism of the traditional Chinese medicine aiming at the disease is rare, and the research of the action mechanism and the action target point still lacks experimental basis.
The invention relates to a formula which is distinguished from Jingyue quan Shu & cough and aims to overcome the defect that body fluid in lung is insufficient and withers and falls when cough happens, and the formula comprises radix stemonae, myrobalan, ephedra herb, cortex mori radicis, radix scutellariae, radix asteris, indigo naturalis, sea clam powder and cortex dictamni. In the formula, the stemona root is sweet, moist, bitter and descending, slightly warm and not dry, enters lung channels, has the effect of moistening lung to relieve cough, the myrobalan is sour, astringent and bitter, can lower energy, can astringe lung qi to relieve cough, can clear lung heat, relieve sore throat and produce sound, and the two medicines are used for moistening lung and astringing transverse reversed flow of liver qi; the ephedra herb is pungent, bitter and warm, has ascending and dispersing properties, the mulberry bark has sweet taste, is cold in nature and descends, can lower adverse qi in the lung and purge stagnated heat in the lung, and has the advantages of ascending, descending, immediate relief and moderate opening and closing; scutellariae radix, for clearing lung heat, eliminating phlegm, and relieving cough and asthma; natural indigo, for clearing liver fire and purging lung heat; haiha powder has the effects of lowering qi and reducing phlegm, and has the effects of moistening lung and reducing phlegm, clearing liver and relieving spasm, and lowering adverse qi and relieving cough with other medicines in a formula. However, the traditional decoction is time-consuming in decoction processing, bitter in taste, large in amount, inconvenient to take and poor in children compliance. Therefore, the invention starts with changing the formulation, improving the drug effect, enhancing the taste and the like, and develops the medicine terminalia fruit Qingjin granules which are convenient to take, safe and effective.
The relevant articles/academic papers and studies that have been published to date in connection with the present invention are based on the following:
[1] influence of Mingxi, Dingjun, Jiuyu Huayun, Wanyan, Xiongyizi, Bai Chebula Qingjin granules on airway inflammation of airway hyperreactivity rats [ J ] Sichuan TCM, 2017, (06):52-55.
[2] Study of clinical efficacy of Mingxi, Wangyan, Qianjiang, Urliu, Chenbojun, Baihe and Qingjin granules on cough after infection of wood fire criminal jin type children [ J ]. proceedings of Hubei university of traditional Chinese medicine 2016,01:51-53.
[3] Liu Rong, Xiu Lei, Xianju, Chen Baijun, Liu Dan, professor of Xiu Lei for treating cough variant asthma experience [ J ]. proceedings of Yunnan college of traditional Chinese medicine 2015,06:90-92.
[4] Liu Rong, Xiu Yi, Xiji Xuan, Wang Advance and Liu Dan summary of TCM treatment of infantile cough variant asthma [ J ] J of TCM pediatrics 2016,02:62-65.
[5] Pandai, li xiaoshan, wuwen, david 32741reed stem decoction, pediatric clinical application experience [ J ]. proceedings of the national academy of traditional Chinese medicine of Yunnan, 2008,05:34-36.
[6] Mingxi, Xiu Lei professor differentiation and treatment of children cough experience [ A ] Chinese medicine society of medicine, pediatrics division, national institute of education, advanced medicine, pediatrics teaching research, No. 24 th national institute of medicine, pediatrics teaching research compilation [ C ] Chinese medicine conference of medicine, pediatrics teaching research, and national institute of education, pediatrics teaching research, 2007:4.
[7] Bear Lei, Li Xiaoshan, He Wen, Dai \32741reedstem decoction, pediatric clinical application experience [ A ] Chinese traditional medicine society, pediatrics division, 25 th national Chinese traditional medicine pediatrics academic seminar and Chinese medicine advanced education, pediatrics teaching research conference, collection [ C ] Chinese traditional medicine society, pediatrics division, 2008:2.
[8] The experience of Yangbai, Xiu Lei Jia Feng ren physicians in treating children's cough is summarized [ J ]. J. TCM J. pediatrics, 2006,03:4-6.
[9] Bear epididymis, Li Xiaoshan, He Wen, three stages of treatment of cough syndrome in children, nine methods [ J ]. proceedings of Yunnan college of traditional Chinese medicine, 2005,03:41-43.
[10] Professor heavenly bear, Yunan academy of traditional Chinese medicine, 2005,01:47-48.
[11] Wangli, Xionglin, Erlingu soup uses ruminant [ J ]. proceedings of Yunnan academy of traditional Chinese medicine, 2004,01:23-24.
[12] Clinical observation of YI Wei Na, Yang Sha bang, Xiong Lei, Xuan Fei Zhi He mixture for treating wind-heat type exogenous cough in children [ J ]. proceedings of Yunnan college of traditional Chinese medicine, 2001,04:13-15.
[13] Xiongliu Yangpang Zhike ten methods introduction [ J ] Yunnan J.TCM 1997,04:13-14.
Disclosure of Invention
The inventor is engaged in the pediatric clinical and teaching work of traditional Chinese medicine for more than 30 years, the clinical effective proved formula of the hundred-myrobalam Qingjin decoction is based on the special clinical manifestations of cough, paroxysmal cough and irritable cough after children are infected, and after the children are chronically cough, the symptoms of liver channel fire hyperactivity such as strange sex, crying and screaming are often appeared, and the physiological and pathological characteristics of the children 'the liver is always surplus and the lung is always insufficient' are combined, so that the disease is considered to be marked with the pathogenesis of 'cough with adverse rising of qi', the diseased position is still in the lung but not separated from the liver, and the treatment should be based on 'clearing liver and relieving spasm, lowering adverse qi and relieving cough'. The Bai He QING JIN TANG has the functions of dispersing lung qi and eliminating phlegm, and clearing liver and lowering adverse qi, and is mainly used for treating cough and shortness of breath, excessive and sticky phlegm, difficult expectoration, yellow and thick color, red tongue with yellow and greasy coating, and rapid and wiry and smooth pulse.
The technical scheme of the invention is composed of 4-30g of honey-fried edestan, 4-30g of fried white mulberry root-bark, 4-30g of fried scutellaria baicalensis, 4-30g of fried aster, 4-30g of radix stemonae, 4-30g of myrobalan, 4-30g of indigo naturalis, 4-30g of sea clam meal, 4-30g of dittany bark, 4-30g of cicada slough, 4-30g of oroxylum indicum, 4-30g of hairyvein agrimonia herb and bud, 4-30g of fried loquat leaf, 4-30g of cortex lycii radicis and 4-30g of almond.
In the formula, the stemona root is sweet, moist, bitter and descended, enters lung channel, is warm but not dry, is good at moistening lung and relieving cough, can be used for treating external infection and internal injury, new cough, chronic cough and cold and heat, is an essential drug for treating chronic cough and deficiency cough, is sour, astringent, bitter and flat, enters lung and large intestine channels, can reduce energy, can astringe lung qi and relieve cough, can clear lung and relieve sore throat and produce sound, astringes intestines and stops diarrhea, and is particularly suitable for chronic cough, vomiting and vomiting with severe constipation; the two herbs are combined to moisten lung and astringe lung, astringe qi of lung and intestine, and mother and child are combined to be the monarch herbs. Bai Qin is bitter and cold in nature, mainly enters lung meridian and is good at clearing lung heat in upper energizer; indigo naturalis is salty in flavor and cold in nature, enters liver and lung meridians, and clears liver fire to purge lung heat; the sea clam powder is salty and cold in nature, clears away the lung-heat and reduces phlegm, eliminates stubborn phlegm and prevents chronic diseases, has pungent and slightly bitter taste and descending property, enters lung and bladder channels, can open the stasis of skin and hair outside to ensure that lung qi is smooth, pathogenic wind is dispersed from the exterior, can reduce the adverse qi in the interior, has the effect of relieving asthma by recovering the normal descending function of the lung, is an important medicine for mainly treating asthma and cough caused by the obstruction of the lung qi, has the sweet and cold taste of the white mulberry root-bark, mainly enters the lung channels, can clear lung fire and purge water and gas in the lung to relieve asthma, is used for clearing lung heat and purging liver fire to eliminate stubborn phlegm and regulating qi activity as ministerial medicines; aster tataricus is sweet, moist, bitter and lax, warm in nature but not hot, moist in nature but not dry, and good at moistening lung and descending qi, opening lung depression, resolving phlegm and turbidity and relieving cough; the Indian mockstrawberry herb is bitter, sweet and cool, enters lung channel, clears lung heat and relieves sore throat, soothes liver and harmonizes stomach, is hairyvein agrimony, is bitter, astringent and flat, can astringe and tonify deficiency, is bitter and slightly cold in loquat leaf taste, clears lung heat and relieves cough, relieves cough and asthma, strengthens the effects of clearing liver and purging fire, astringes lung and relieving cough, and is an adjuvant drug; the cortex dictamni is bitter in taste and cold in nature, clears heat and dries dampness, dispels wind and relieves itching, and the periostracum cicadae is sweet and cold in taste, dispels wind and dissipates heat, relieves sore throat and makes sound; cortex lycii radicis sweet and cold, can clear away lung heat and reduce deficient fire, and almond is bitter, slightly pungent and warm, can relieve cough and asthma, and can relax bowel; the above herbs are used as guiding herbs together, to dispel wind, relieve itching, moisten intestines, relieve constipation and make phlegm-fire out of the way. The formula has strict compatibility, combines the functions of clearing liver and moistening lung, and combines the functions of dispersing lung qi and lowering qi to play the effects of nourishing yin and moistening dryness, clearing liver and dispersing lung qi, dispersing lung qi and relieving cough, eliminating phlegm and moistening intestines. Clinical application proves that the cough-relieving traditional Chinese medicine composition has the advantages of rapid cough relieving, difficulty in relapse and less side effect. Particularly, after the cicada slough, the oroxylum indicum, the agrimony, the roasted loquat leaf, the cortex lycii radicis, the almond and other raw material medicines are added, the lung ventilating and cough relieving effects of the original formula can be enhanced, the stomach invigorating and deficiency tonifying effects are improved according to the characteristics of children, and a remarkable effect is obtained.
The invention aims to provide the myrobalan Qingjin granules which have remarkable effect and are used for treating infantile cough. The technical scheme is as follows:
the myrobalan Qingjin granules are characterized by comprising the following raw materials in parts by weight: 4-30g of radix stemonae, 4-30g of myrobalan, 4-30g of fried scutellaria baicalensis, 4-30g of indigo naturalis, 4-30g of sea clam meal, 4-30g of honey-fried edestan, 4-30g of fried white mulberry root-bark, 4-30g of fried aster, 1-30g of oroxylum indicum, 4-30g of hairyvein agrimonia herb and bud, 4-30g of fried loquat leaf, 4-30g of dittany bark, 2-30g of cicada slough, 4-30g of cortex lycii radicis and 4-30g of almond; the radix Stemonae is radix Stemonae or radix Stemonae processed with Mel.
Further preferably, the weight ratio of each component is as follows: 20-30g of radix stemonae, 20-30g of myrobalan, 15-25g of fried scutellaria baicalensis, 8-18g of indigo naturalis, 8-18g of sea clam meal, 15-25g of honey-fried edestan, 15-25g of fried white mulberry root-bark, 15-25g of fried aster, 3-25g of oroxylum indicum, 15-25g of hairyvein agrimonia herb and bud, 8-18g of fried loquat leaf, 8-18g of dittany bark, 5-18g of cicada slough, 5-15g of cortex lycii radicis and 5-15g of almond.
Further preferably, the weight ratio of each component is as follows: 25g of radix stemonae, 25g of myrobalan, 20g of fried scutellaria baicalensis, 10g of indigo naturalis, 10g of sea clam powder, 20g of honey-fried edestan, 20g of fried white mulberry root-bark, 20g of fried aster, 5g of oroxylum indicum, 20g of hairyvein agrimonia herb, 15g of fried loquat leaf, 10g of dittany bark, 10g of cicada slough, 10g of cortex lycii radicis and 10g of almond.
In particular, the efficacy of the drug is as follows:
radix Stemonae is sweet, moist, bitter and descending, warm and not dry, enters lung meridian, and has the special effect of moistening lung to arrest cough. Ming Yi Bie Lu (miscellaneous records of famous physicians) governing cough and ascending qi. The pottery and the potpourri are considered as' treating cough by processing wine stain with Bai fire and drinking. In addition, dust mite is a common and harmful allergen recognized globally, and radix stemonae has insecticidal efficacy and indirectly treats the disease. Modern researches show that radix stemonae contains various alkaloids, wherein the stemonine can reduce respiratory center excitation and has the effects of relieving cough, eliminating phlegm and relieving asthma. In addition, the 3, 5-dihydroxy-4-methyl biphenyl has the effects of inhibiting cancer cells, promoting various immune functions and antagonizing the effect of cyclophosphamide on reducing the immune function of the organism.
Myrobalan is bitter, sour and astringent in taste and neutral in nature. It enters lung and large intestine meridians. Has the functions of astringing lung, relieving cough, relieving sore throat and producing sound. Sour flavor enters liver, can astringe and descend, astringe lung and descend qi to relieve cough, clear liver and relieve sore throat to produce sound. It is used clinically in treating lung deficiency, dyspnea with cough, chronic cough, pharyngalgia, hoarseness and other diseases. The Ben Jing He Jie Yuan (the origin of Ben Jing meeting), unprocessed Qing jin Zhi Shu, stewed to strengthen the spleen to check diarrhea. Modern researches show that the myrobalan has spasmolytic effect on smooth muscle. The results of clinical strain bacteriostasis tests of 335 strains on the myrobalan decoction show that the myrobalan has good bacteriostasis to gram-positive cocci and 90% of bacteriostasis concentration to staphylococcus aureus, staphylococcus epidermidis, escherichia coli, pseudomonas aeruginosa and enterococcus faecalis.
Scutellaria baicalensis Georgi is dried root of Scutellaria baicalensis Georgi of Labiatae. Collected in spring and autumn, removed fibrous root and silt, dried in the sun, removed the rough skin, and dried in the sun. Clear heat and dry dampness, purge fire and remove toxicity, stop bleeding, prevent abortion. Can be used for treating chest distress, nausea, damp-heat, dysentery, jaundice, cough due to lung heat, hyperpyrexia, polydipsia, hematemesis, carbuncle, swelling, sore, and threatened abortion.
Qing Dai is salty in flavor and cold in nature. It enters liver meridian. Has the functions of clearing liver-fire, clearing heat and detoxicating. Mainly clear liver fire and purge lung heat, it is commonly used for cough due to liver fire invading lung. The book Jing meets the former, it is said to purge liver and gallbladder and dispel stagnated fire. Modern researches have shown that indigo naturalis and indigo naturalis have antiviral and hepatoprotective effects. In addition, it has effects in dilating cardiovascular system, resisting hepatitis B virus, and resisting cancer.
Hai Ge fen is salty, cold in nature, non-toxic and natural by the yin qi in water. Decrease the rate. Yin is also involved. Those who are recorded in the sea. It is different from the generation of Jianghu and Di ze. Mainly heat-phlegm. Dampness-phlegm. Old phlegm. Stubborn phlegm. Hernia is caused. White turbidity. With leucorrhea. Enter heart and kidney meridians. It is a soft, hard and moist herb.
Ma Huang is pungent in flavor and warm in nature. It enters lung and bladder meridians. Has the functions of ventilating lung and relieving asthma. Can open the stasis of skin and hair to make the lung qi smooth and the pathogenic wind disperse; the ascending qi is descending, so that the lung governs descending. It excels at relieving dyspnea, and is the key herb for dyspnea and cough due to lung qi obstruction. Moxibustion Ma Huang has stronger action of moistening lung than raw Ma Huang. Shen nong Ben Cao Jing (Shen nong's herbal), where Ma Huang relieves cough and reverses the flow of qi upward. Modern researches have shown that ephedra mainly contains various components such as ephedrine, pseudoephedrine, methyl pseudoephedrine and the like. Ephedrine in the mix-fried ephedra has obvious relaxation effect on bronchial smooth muscle, and volatile oil of the mix-fried ephedra has strong inhibition effect on influenza virus; the ephedrine has long spasmolytic effect on bronchial smooth muscle, and especially has more remarkable effect when the bronchus is in a spastic state. The effects of ephedra such as asthma relieving, inflammation resisting, allergy resisting and the like are the pharmacological basis of freeing lung and relieving asthma.
Sang Bai Pi is sweet in flavor, cold in nature and descending, mainly enters lung meridian, and has the actions of purging lung fire, relieving asthma, inducing diuresis and relieving swelling. It can clear lung fire, purge water and qi in lung to relieve dyspnea, induce diuresis to alleviate edema to treat eye edema. The treatise on the lung-qi dyspnea with fullness and distention is published in the treatise on the property of herbs. The book of medical science: "purging excess of lung, not sang Pi". The miscellaneous records of famous physicians: it is used to eliminate lung water, stop saliva and blood, and to quench thirst and edema. Modern researches show that the acetone extract of the white mulberry root-bark has obvious effects of relieving cough and eliminating phlegm, and the inhibition effect of the processed honey-fried white mulberry root-bark water extract on the cough of mice caused by sulfur dioxide is obviously stronger than that of the raw white mulberry root-bark. The acetone extract has antiasthmatic effect by increasing the content of Nitric Oxide (NO) in trachea and relaxing smooth muscle of bronchus, and scopoletin (6-methoxy-7-hydroxy-coumarin) is considered as the effective antiasthmatic component of cortex Mori. In addition, it also has analgesic, antiinflammatory, immunity regulating, platelet aggregation inhibiting, blood vessel dilating, diuretic, and blood glucose lowering effects.
Tatarian aster root, radix Asteris, bitter in flavor and warm in nature. The functional indications are as follows: warm lung, descend qi, resolve phlegm and relieve cough. It is used to treat cough and asthma due to wind-cold evil, cough with pus and blood, throat impediment, and dysuria.
Qian Bing Wan is named as Mao Wan, because the wood is like hyacinth bean and big, the middle is like accumulated paper, the wood is like cicada's wing, and the pieces are full of the middle, it is named as Mao Ling Qian paper. Entering lung meridian, relieving asthma, and eliminating phlegm; enter the spleen and stomach meridians to break venomous food stagnation, circulate qi and blood of the twelve meridians to remove the toxic substances of venomous food and qi venomous food. It can also tonify deficiency, relieve epigastric distention and eat food. In the national region, the herb is called three hundred and two silver herbs, so it is also indicated for parasitic tympanties.
Herba et Gemma Agrimoniae has effects of invigorating stomach and tonifying deficiency. It is indicated for hemoptysis, hematemesis, hematuria, hematochezia, red and white dysentery, metrorrhagia and metrostaxis, leukorrhagia, traumatic injury, carbuncle and swelling, traumatic hemorrhage.
Loquat leaves can clear away lung-heat, relieve cough, harmonize stomach, check adverse rise of qi, and quench thirst. Lung heat with phlegm cough; cough due to yin deficiency; hemoptysis; bleeding; vomiturition due to stomach heat.
Cicada slough can dispel wind-heat, ventilate lung and relieve spasm. It is used to treat wind-heat common cold, cough, hoarseness, measles without adequate eruption, rubella, infantile convulsion, conjunctival congestion, nebula, furuncle, toxic swelling, and tetanus.
Cortex Lycii, being effective in clearing heat and cooling blood. It is used to treat tidal fever and night sweat due to asthenia, cough and asthma due to lung heat, hematemesis, epistaxis, stranguria with blood, diabetes, hypertension, carbuncle, swelling, and skin ulcer.
Semen Armeniacae amarum, dried seeds of bitter taste of Prunus Armeniaca or Prunus Armeniaca of Rosaceae. Picking in summer when fruit is mature, removing pulp and core shell, taking out kernel, and air drying. Placing in shady and dry place for preventing worm damage. Eliminating phlegm and relieving cough; relieving asthma; moistening intestines; descending qi and relieving arthralgia. Cough due to exogenous pathogenic factors; gasp and fullness; impairment by dryness with cough; cold running dolphin; fright epilepsy; chest stuffiness; epigastric pain due to food stagnation; metrorrhagia; deafness; malnutrition with swelling; stranguria due to damp-heat; scabies; pharyngitis; constipation due to intestinal dryness.
In conclusion, the myrobalan Qingjin formula is rigorous in prescription, exquisite in compatibility, and suitable for the physiological and pathological characteristics of 'more frequent liver and frequent insufficiency of lung' of children and the etiology of 'wind and adverse qi', is gentle and flexible in medication, and abandons a group of cold and cool drugs due to the trend of guiding, and is selected to ventilate lung and descend qi, clear liver and purge lung, and moisten lung and relieve cough. Therefore, the cough relieving effect is good, the recurrence is not easy, and the cough symptoms and accompanying symptoms of children with cough variant asthma can be obviously improved.
The preparation method of the myrobalan Qingjin granules comprises the following steps:
the fructus terminaliae Billericae Qingjin granules are prepared by decocting the medicinal materials in water twice, adding 4-10 times of water for the first time, adding 4-10 times of water for the second time, decocting for 1-4 hours each time, filtering, collecting filtrate, concentrating, drying, adding a proper amount of dextrin and sucrose, and preparing into granules.
The fructus terminaliae Billericae Qingjin granules are prepared by decocting the medicinal materials in water twice, adding 8 times of water for the first time, adding 6 times of water for the second time, decocting for 2 hours each time, filtering, collecting filtrate, concentrating, drying, adding a proper amount of dextrin and sucrose, and preparing into granules.
The myrobalan Qingjin granules are prepared by adding 95% ethanol into the medicinal materials for refluxing twice, adding 4-10 times of ethanol for the first time, adding 4-10 times of ethanol for the second time, wherein the refluxing time is 0.5-2 hours each time, filtering, collecting filtrate, concentrating, drying, adding a proper amount of dextrin and sucrose, and preparing into granules.
The myrobalan Qingjin granules are prepared by adding 95% ethanol into the medicinal materials for refluxing twice, adding 8 times of ethanol for the first time and 6 times of ethanol for the second time, wherein the refluxing time is 0.5-2 hours each time, filtering, collecting filtrate, concentrating, drying, adding a proper amount of dextrin and sucrose, and preparing into granules.
The fructus terminaliae Billericae Qingjin granules can be prepared into dosage forms of granules, paste, pills, oral liquid, pills, powder, dripping pills, capsules and the like according to actual needs.
Detailed Description
Example 1 preparation example of Terminalia Billerica Qingjin granules
Selecting raw material medicines of 20g of radix stemonae, 20g of myrobalan, 20g of fried scutellaria baicalensis, 10g of indigo naturalis, 10g of sea clam meal, 25g of honey-fried edestan, 25g of fried white mulberry root-bark, 20g of fried aster, 5g of oroxylum indicum, 20g of hairyvein agrimonia herb, 15g of fried loquat leaf, 10g of dittany bark, 10g of cicada slough, 10g of cortex lycii radicis and 10g of almond; decocting the above materials in water twice, adding 4-10 times of water for the first time, adding 4-10 times of water for the second time, decocting for 1-4 hr each time, filtering, collecting filtrate, concentrating, drying, adding appropriate amount of dextrin and sucrose, and making into granule.
Example 2 preparation example of Terminalia Billerica Qingjin granules
Selecting raw material medicines of 20g of radix stemonae, 20g of myrobalan, 20g of fried scutellaria baicalensis, 10g of indigo naturalis, 10g of sea clam meal, 25g of honey-fried edestan, 25g of fried white mulberry root-bark, 20g of fried aster, 5g of oroxylum indicum, 20g of hairyvein agrimonia herb, 15g of fried loquat leaf, 10g of dittany bark, 10g of cicada slough, 10g of cortex lycii radicis and 10g of almond; adding 8 times of water into the medicinal materials, refluxing for two times by using 50-95% ethanol, adding 8 times of ethanol for the first time, adding 6 times of ethanol for the second time, wherein the refluxing time is 0.5-2 hours each time, filtering, collecting filtrate, concentrating, drying, adding a proper amount of dextrin and sucrose, and preparing into granules.
Example 3 preparation example of Terminalia Billerica Qingjin granules
Selecting 30g of radix stemonae, 30g of myrobalan, 25g of fried scutellaria baicalensis, 8g of indigo naturalis, 8g of sea clam powder, 20g of honey-fried edestan, 20g of fried white mulberry root-bark, 15g of fried aster, 5g of oroxylum indicum, 15g of hairyvein agrimonia herb and bud, 20g of fried loquat leaf, 12g of dittany bark, 8g of cicada slough, 5g of cortex lycii radicis and 5g of almond as raw materials; decocting the above materials in water twice, adding 8 times of water for the first time and 8 times of water for the second time, decocting for 3 hr each time, filtering, collecting filtrate, concentrating, drying, adding appropriate amount of dextrin and sucrose, and making into granule.
EXAMPLE 4 efficacy test for treatment of infantile cough
150 children with cough variant asthma with liver-fire attacking lung meeting the inclusion criteria were randomly divided into 50 patients in each of the treatment group, control 1 group and control 2 group.
The oral medicine of fructus terminaliae bellericae and Qingjin granules is prepared according to the preparation method of the medicine in the embodiment 1.
Control 1 group was inhaled by combined nebulization of budesonide suspension and terbutaline sulfate nebulization solution.
The preparation method of the oral control granule for the control 2 groups comprises the following steps: 25g of radix stemonae, 25g of myrobalan, 20g of fried scutellaria baicalensis, 10g of indigo naturalis, 10g of hayata powder, 25g of honey-fried edestan, 25g of fried white mulberry root-bark, 20g of fried aster, 5g of oroxylum indicum, 20g of hairyvein agrimonia herb, 10g of cortex lycii radicis, 10g of almond and 5g of liquorice; decocting the above materials in water twice, adding 4-10 times of water for the first time, adding 4-10 times of water for the second time, decocting for 1-4 hr each time, filtering, collecting filtrate, concentrating, drying, adding appropriate amount of dextrin and sucrose, and making into granule.
Three groups were treated continuously for 14 days. Compared with the children patients in the treatment group and the control group, the differences in age, sex, disease course and the like have no statistical significance (P >0.05) and are comparable. The total effective rate of the treatment group is 92%, the total effective rate of the control group 1 is 86%, the total effective rate of the control group 2 is 84%, the total curative effect of the treatment group is better than that of the control group, and the difference has statistical significance (P is less than 0.05).
Example 5 Effect on airway inflammation in airway hyperresponsiveness rat
The purpose is as follows: observing the interference effect of the myrobalan qingjin granules on airway inflammation of the rat with airway hyperresponsiveness. The method comprises the following steps: randomly dividing 48 SD rats into a blank group, a model group, a dexamethasone group and a myrobalan gold-clearing granule low, medium and high dose groups, wherein each group comprises 8 rats; ovalbumin was used for sensitization, replicating the airway hyperreactivity rat model. Recording the total number and the classified count of the white blood cells in each group of bronchoalveolar lavage fluid (BALF) according to the experimental plan for dry prognosis; detecting the content of interleukin-4 (IL-4), interleukin-6 (IL-6), interferon-gamma (IFN-gamma) and tumor necrosis factor (TNF-alpha); and observing the pathological features of HE staining of lung tissues. As a result: the myrobalan Qingjin granules with high and medium dosage can obviously reduce the quantity of leucocytes, eosinophils (P is less than 0.001) and neutrophils (P is less than 0.05) in the BALF of the rat with high airway response, and reduce the inflammatory injury of lung tissues. Compared with the blank group, the model group has obviously increased IL-4, IL-6 and TNF-alpha levels (P < 0.001) and obviously reduced IFN-gamma levels (P < 0.001). The high-dose group can obviously reduce the expression of IL-4(P is less than 0.001), IL-6 and TNF-alpha (P is less than 0.01), and increase the level of IFN-gamma (P is less than 0.01), and the effect is equivalent to that of the nostoc; although the IL-4 and TNF-alpha levels in the medium and low dose groups are obviously lower than those in the model group, the difference has no statistical significance. And (4) conclusion: the fructus terminaliae billericae Qingjin granules can inhibit airway inflammatory reaction of rats with airway hyperresponsiveness, reduce airway hyperresponsiveness and have an obvious dose-effect relationship; this may be part of the mechanism of action for treating diseases with increased airway reactivity, such as cough after infection.
Specific experimental details can be found in published articles: mingxi et al, Bai He Qing jin granules influence on airway inflammation in rat with airway hyperresponsiveness, Sichuan TCM, 35 vol.6 th in 2017, page 52-55. The myrobalan Qingjin granules adopted in the method are the granules prepared in the example 1 of the invention.
Example 6 animal test for antitussive Effect
60 guinea pigs were randomly divided into 3 groups of 20 animals each. One week before the experiment, the stomach is perfused and administrated 2 times every day, each time the stomach is administrated 2mL/100g, the experiment is administrated 1 time on the day, 2 hours later, the guinea pig is placed into a spraying device, ammonia water is sprayed at a constant speed, the time from the spraying to the cough and the times within 3min after the cough is started are recorded, and T test is carried out on the result.
The treatment group adopts fructus terminaliae terminalia granules prepared in example 1 to carry out intragastric administration;
the negative control group adopts normal saline for gastric perfusion administration;
the positive control group adopts the Kebiqing and the intragastric administration, and the dosage is as follows: 500mg/100 g.
The results are shown in the following table:
comparison of latency and cough frequency in rats of each group
The results confirmed that: the treatment group can obviously prolong the cough latency period and reduce the cough frequency, has significant difference (P <0.05) compared with a negative control group, and has no significant difference compared with the effect of a positive control group.
Example 7 exemplary diseases
The first medical record is:
wangzhi, female, 6 years old, 2016, 7 months and 12 days for diagnosis.
Cough is more than half a year, especially at night, with difficulty in expectoration, nasal obstruction, thick nasal discharge, profuse sweating, pale red tongue with white greasy coating, poor appetite, dry stool.
Allergy to milk and egg.
Checking: pharynx red (+), bilateral tonsil swelling at I degree, heart and lung (-)
Preparing a formula: bai He Qing jin Jie (Bai He Qing jin granule).
Decoct them with boiling water for 6 doses.
The second medical record:
cao Zhi, woman, 4 years old. The physician needs to see the disease 3, 2 days in 2015.
Cough for 2 weeks, occasional cough, no nasal obstruction, sweating, defecation for 2-3 times/day, thin nature, clear urine, red tongue with yellow and greasy coating.
Checking: pharynx red (+), heart and lung (-).
Preparing a formula: bai He Qing jin Jie (Bai He Qing jin granule).
Decocted in cold water for 6 doses to heal.
The third medical record:
zhu Ching, male, 3 years old. The doctor is treated 5 months and 3 days in 2014.
Cough for more than 1 month, especially at night, difficult expectoration with phlegm, sneezing, no nasal discharge, nasal obstruction, poor sleep, large and clear tongue with red tongue and yellow and greasy coating.
Checking: pharynx red (++), bilateral tonsil II degree enlargement, cardiopulmonary (-)
Preparing a formula: bai He Qing jin Jie (Bai He Qing jin granule).
Decocted in cold water for 6 doses to heal.
The fourth medical record:
zhao, a man, 15 years old. The doctor visits 10 months and 20 days in 2013.
Cough is more than 1 month, especially at night. There are symptoms of difficult expectoration of phlegm, pharyngalgia, pharynx itch, thick nasal discharge, nasal obstruction, pain in the occiput, low fever, profuse sweating, constipation, poor sleep, red tongue with thick and greasy coating.
Checking: pharynx red (+), heart and lung (-).
Preparing a formula: bai He Qing jin Jie (Bai He Qing jin granule).
Decoct them with boiling water for 6 doses.
The fifth medical record is:
jiang some, women, 4 years old. Visit 3/16/2012.
Cough for more than 4 days, especially in the morning, with difficult expectoration, thick nasal discharge, no nasal obstruction, constipation, dry stool followed by thin stool, poor sleep, profuse sweating, red tongue with white greasy coating.
Checking: pharynx red (+), bilateral tonsil swelling at I degree, heart and lung (-)
Preparing a formula: bai He Qing jin Jie (Bai He Qing jin granule).
Decoct them with boiling water for 6 doses.
Claims (10)
1. A fructus terminaliae billericae Qingjin particle for treating cough after children infection is characterized by comprising the following raw material medicines: 4-30g of radix stemonae, 4-30g of myrobalan, 4-30g of fried scutellaria baicalensis, 4-30g of indigo naturalis, 4-30g of sea clam meal, 4-30g of honey-fried edestan, 4-30g of fried white mulberry root-bark, 4-30g of fried aster, 1-30g of oroxylum indicum, 4-30g of hairyvein agrimonia herb and bud, 4-30g of fried loquat leaf, 4-30g of dittany bark, 2-30g of cicada slough, 4-30g of cortex lycii radicis and 4-30g of almond; the radix Stemonae is radix Stemonae or radix Stemonae processed with Mel.
2. The myrobalan Qingjin particle of claim 1, which comprises the following components in parts by weight: 20-30g of radix stemonae, 20-30g of myrobalan, 15-25g of fried scutellaria baicalensis, 8-18g of indigo naturalis, 8-18g of sea clam meal, 15-25g of honey-fried edestan, 15-25g of fried white mulberry root-bark, 15-25g of fried aster, 1-10g of oroxylum indicum, 15-25g of hairyvein agrimonia herb and bud, 8-18g of fried loquat leaf, 8-18g of dittany bark, 2-18g of cicada slough, 5-15g of cortex lycii radicis and 5-15g of almond.
3. The myrobalan Qingjin particle of claim 2, which comprises the following components in parts by weight: 25g of radix stemonae, 25g of myrobalan, 20g of fried scutellaria baicalensis, 10g of indigo naturalis, 10g of sea clam powder, 20g of honey-fried edestan, 20g of fried white mulberry root-bark, 20g of fried aster, 5g of oroxylum indicum, 20g of hairyvein agrimonia herb, 15g of fried loquat leaf, 10g of dittany bark, 10g of cicada slough, 10g of cortex lycii radicis and 10g of almond.
4. A method for preparing fructus Chebulae Qingjin granules of claim 1, which comprises decocting the above herbs in water twice, the first time adding 4-10 times of water, the second time adding 4-10 times of water, each time decocting for 1-4 hr, filtering, collecting filtrate, concentrating, drying, adding appropriate amount of dextrin and sucrose, and granulating.
5. A method for preparing fructus Chebulae Qingjin granules as claimed in any one of claims 1-3, which comprises refluxing the above herbs with 95% ethanol twice, 4-10 times of ethanol for the first time and 4-10 times of ethanol for the second time, each refluxing time being 0.5-2 hr, filtering, collecting filtrate, concentrating, drying, adding appropriate amount of dextrin and sucrose, and granulating.
6. A fructus terminaliae bellericae and Qingjin traditional Chinese medicine composition for treating cough after children are infected is characterized by comprising the following raw material medicines: 4-30g of radix stemonae, 4-30g of myrobalan, 4-30g of fried scutellaria baicalensis, 4-30g of indigo naturalis, 4-30g of sea clam meal, 4-30g of honey-fried edestan, 4-30g of fried white mulberry root-bark, 4-30g of fried aster, 1-30g of oroxylum indicum, 4-30g of hairyvein agrimonia herb and bud, 4-30g of fried loquat leaf, 4-30g of dittany bark, 2-30g of cicada slough, 4-30g of cortex lycii radicis and 4-30g of almond; the radix Stemonae is radix Stemonae or radix Stemonae processed with Mel.
7. The fructus terminaliae bellericae heat-clearing traditional Chinese medicine composition according to claim 6, wherein the weight ratio of each component is as follows: 20-30g of radix stemonae, 20-30g of myrobalan, 15-25g of fried scutellaria baicalensis, 8-18g of indigo naturalis, 8-18g of sea clam meal, 15-25g of honey-fried edestan, 15-25g of fried white mulberry root-bark, 15-25g of fried aster, 3-25g of oroxylum indicum, 15-25g of hairyvein agrimonia herb and bud, 8-18g of fried loquat leaf, 8-18g of dittany bark, 5-18g of cicada slough, 5-15g of cortex lycii radicis and 5-15g of almond.
8. The fructus terminaliae bellericae heat-clearing traditional Chinese medicine composition according to claim 7, wherein the weight ratio of each component is as follows: 25g of radix stemonae, 25g of myrobalan, 20g of fried scutellaria baicalensis, 10g of indigo naturalis, 10g of sea clam powder, 20g of honey-fried edestan, 20g of fried white mulberry root-bark, 20g of fried aster, 5g of oroxylum indicum, 20g of hairyvein agrimonia herb, 15g of fried loquat leaf, 10g of dittany bark, 10g of cicada slough, 10g of cortex lycii radicis and 10g of almond.
9. The fructus terminaliae bellericae qingjin traditional Chinese medicine composition according to any one of claims 6 to 8, wherein the dosage form of the fructus terminaliae bellericae qingjin traditional Chinese medicine composition is as follows: granule, unguent, pill, oral liquid, pill, powder, or capsule.
10. A preparation method of the fructus terminaliae Billericae Qingjin traditional Chinese medicine composition according to any one of claims 6 to 8, adding 95% ethanol into the above medicinal materials for refluxing twice, wherein 4 to 10 times of ethanol is added for the first time, and 4 to 10 times of ethanol is added for the second time, the refluxing time is 0.5 to 2 hours each time, filtering, collecting filtrate, concentrating, drying to obtain extract, and preparing a pharmaceutically acceptable preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710739223.3A CN107362311B (en) | 2017-08-25 | 2017-08-25 | Medicine 'Baicheqingjin' for treating cough |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710739223.3A CN107362311B (en) | 2017-08-25 | 2017-08-25 | Medicine 'Baicheqingjin' for treating cough |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107362311A CN107362311A (en) | 2017-11-21 |
CN107362311B true CN107362311B (en) | 2020-12-22 |
Family
ID=60311820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710739223.3A Active CN107362311B (en) | 2017-08-25 | 2017-08-25 | Medicine 'Baicheqingjin' for treating cough |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107362311B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105521386A (en) * | 2016-01-21 | 2016-04-27 | 郏县妇幼保健院 | Traditional Chinese medicinal composition for treating cough with syndrome of liver fire invading lung in children |
-
2017
- 2017-08-25 CN CN201710739223.3A patent/CN107362311B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105521386A (en) * | 2016-01-21 | 2016-04-27 | 郏县妇幼保健院 | Traditional Chinese medicinal composition for treating cough with syndrome of liver fire invading lung in children |
Non-Patent Citations (5)
Title |
---|
从肝论治小儿过敏性咳嗽;肖挹等;《实用医院临床杂志》;20080531;第5卷(第03期);第135页,第1.2节 * |
咳嗽治案三则;《新中医》;19850915(第09期);第19页 * |
清肺降气汤治疗咳嗽298例;王瑾;《云南中医中药杂志》;20020620;第23卷(第03期);第25页,第2.1节 * |
百和清金颗粒治疗木火刑金型儿童感染后咳嗽的临床疗效研究;明溪等;《湖北中医药大学学报》;20160229;第18卷(第1期);第51-53页 * |
自拟宣肺利咽止咳方结合西药治疗喉源性咳嗽疗效观察;唐晓波;《中华中医药学刊》;20070228;第25卷(第02期);第241-242页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107362311A (en) | 2017-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103933425A (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method thereof | |
CN103751579B (en) | Treatment nasopharyngeal carcinoma radiotherapy pharmaceutical composition causing oral mucositis and preparation method thereof | |
CN104001045A (en) | Drug for treating dog pneumonia and preparation method thereof | |
CN103623372A (en) | Medicine for treating trachitis | |
CN111097021A (en) | Traditional Chinese medicine composition for treating mild and suspected new coronary pneumonia and acute respiratory infection | |
CN107737288B (en) | Traditional Chinese medicine composition for treating allergic asthma and preparation method thereof | |
CN103417875B (en) | A kind of Chinese medicine preparation for the treatment of chronic bronchitis and preparation method thereof | |
CN113209194B (en) | Composition for treating chronic gastritis and preparation method and application thereof | |
CN107362311B (en) | Medicine 'Baicheqingjin' for treating cough | |
CN107753664B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
CN105535730A (en) | Novel traditional Chinese medicine composition for treating coughs and preparation method thereof | |
CN111632080A (en) | Formula for treating drug eruption dermatitis, preparation method and application | |
CN105327182A (en) | Medicine for treating child pertussis and preparation method thereof | |
CN104623410A (en) | Traditional Chinese medicine for treating radiation pneumonitis | |
CN105396017A (en) | Traditional Chinese medicine preparation used for treating fatty liver, and preparation method thereof | |
CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
CN103239603A (en) | Traditional Chinese medicine for treating bronchitis | |
CN103638513A (en) | Pectoral syrup for tonifying spleen and nourishing stomach | |
CN103142989B (en) | Traditional Chinese medicine composition for treating infantile cough and preparation method thereof | |
CN107582939B (en) | A Chinese medicinal composition for treating chronic bronchitis, and its preparation method | |
CN107753584B (en) | Chinese ephedra anti-allergic traditional Chinese medicine composition and preparation method thereof | |
CN105148090A (en) | Traditional Chinese medicine preparation for nursing throat and lung diseases | |
CN110882344A (en) | Traditional Chinese medicine formula for treating throat itching and cough and preparation method thereof | |
CN104524187A (en) | Traditional Chinese medicine preparation for treating swollen sore throats and production method of traditional Chinese medicine preparation | |
CN104189870A (en) | Traditional Chinese medicine for treating allergic asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Yunnan University of traditional Chinese medicine, 1076 Yuhua Road, Chenggong New Town, Kunming, Yunnan 650500 Patentee after: Yunnan University of Traditional Chinese Medicine Address before: Yunnan University of traditional Chinese medicine, 1076 Yuhua Road, Chenggong New Town, Kunming, Yunnan 650500 Patentee before: YUNNAN University OF TRADITIONAL CHINESE MEDICINE |